China Pharma Holdings, Inc.
CPHI
$0.65
-$0.01-1.39%
AMEX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.19% | 41.72% | 63.26% | 17.82% | 0.63% |
| Total Depreciation and Amortization | 13.02% | -48.92% | -56.59% | -55.12% | -27.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -135,010.89% | 114.54% | -27.93% | 70.77% | -3,466.67% |
| Change in Net Operating Assets | 1,307.71% | -115.72% | -13.68% | 138.25% | 99.75% |
| Cash from Operations | -49.13% | -404.26% | 500.41% | 90.12% | 1,439.91% |
| Capital Expenditure | 97.44% | -106.52% | 100.36% | -- | -333.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.91% | -- | -- | -- | -- |
| Cash from Investing | 97.87% | -541.30% | 64.77% | -- | -5,964.44% |
| Total Debt Issued | 10,305.88% | -10,985.29% | 96.19% | -- | -99.36% |
| Total Debt Repaid | -1,176.92% | -- | -106.19% | -- | 94.09% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 1.45% | -1.45% | -- |
| Cash from Financing | -33.70% | -1,897.06% | -523.19% | -1,114.49% | -278.62% |
| Foreign Exchange rate Adjustments | 106.15% | 315.69% | -607.14% | 19.40% | -225.79% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 184.42% | -1,634.95% | 313.37% | 63.38% | -270.00% |